Skip to main content

Teladoc Health Earns Multiple Telehealth Accreditations from ClearHealth Quality Institute

PURCHASE, NY, Nov. 14, 2019 (GLOBE NEWSWIRE) — Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced it has earned two accreditations through ClearHealth Quality Institute’s Telemedicine Accreditation Program (TAP). The company gained independent accreditation for both its Consumer-to-Provider services for acute care needs, as well as its Provider-to-Consumer services, which focus on the ongoing provider/patient relationship when treating specialty and chronic conditions, including mental health.
“Delivering high-quality clinical care is at the heart of Teladoc Health’s mission. It’s central to our commitment to lead by example and elevate virtual care standards for ourselves, our members, and for the industry,” said Jason Tibbels, MD, chief quality officer, Teladoc Health.To achieve CHQI accreditation for telemedicine, Teladoc Health completed a robust application process spanning both business and clinical operations. It demonstrated the company’s long-term commitment to deliver the highest caliber of care in the industry, as evidenced by Teladoc Health’s other market-leading initiatives such as establishing the first and only Patient Safety Organization (PSO) for virtual care and research into antibiotic stewardship with USC.  “As more consumers depend on virtual care, they seek assurances that it is quality care, particularly as not all telemedicine providers set quantifiable care metrics. Consumers, medical providers, employers, and insurers alike generally feel more comfortable and more confident relying on healthcare entities that have secured accreditation,” said Michael Gomes, CEO, CHQI. “By becoming a CHQI-accredited organization for telemedicine in two areas, Teladoc Health reaches a new standard of quality in the delivery of telemedicine in our country.”For more information, visit TeladocHealth.com.About ClearHealth Quality Institute™ (CHQI)
Founded upon the principles of accountability, integrity, and quality, ClearHealth Quality Institute’s (CHQI) goal is to create innovative accreditation programs and compliance solutions that improve the health insurance and provider systems of care. CHQI’s Telemedicine Accreditation Program and Mental Health Parity/Substance Use Disorder Accreditation Program collectively accredit the nation’s leading health plans, health systems, and telemedicine organizations. CHQI is governed by an independent board and committee system, which is open to a wide range of volunteer members to ensure transparency and accountability. To learn more about CHQI, please contact (410) 756-1300, info@CHQI.com, or visit www.chqi.com.
About Teladoc Health
A mission-driven organization, Teladoc Health, Inc. is successfully transforming how people access and experience healthcare, with a focus on high quality, lower costs, and improved outcomes around the world. The company’s award-winning, integrated clinical solutions are inclusive of telehealth, expert medical services, AI and analytics, and licensable platform services. With more than 2,000 employees, the organization delivers care in 130 countries and in more than 30 languages, partnering with employers, hospitals and health systems, and insurers to transform care delivery. For more information, please visit www.teladochealth.com or follow @TeladocHealth on Twitter.
Media Contact:
Anthony Steel
Weber Shandwick
917-803-1990
asteel@webershandwick.com
Courtney McLeod
914-265-6789
cmcleod@teladochealth.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.